SCHEMBL24492836

SCHEMBL24492836

c1ccc(-n2c3ccncc3c3cc(-c4cc(-c5cccc(-c6cccc(-c7ccncc7)n6)c5)cc(-c5cccc(-c6cccc(-c7ccncc7)n6)c5)c4)ccc32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ CYP19A1 P11511 1/20 0.35
▸ TNF P01375 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ MKNK1 Q9BUB5 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ GABRA1 P14867 1/20 0.34
▸ GABRG2 P18507 1/20 0.34
▸ GABRB3 P28472 1/20 0.34
▸ GABRA5 P31644 1/20 0.34
▸ GABRA3 P34903 1/20 0.34
▸ GRM5 P41594 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ MAPK10 P53779 1/20 0.33
▸ IMPDH2 P12268 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15369843 0.95 CYP19A1 (0.41) MEN1KMT2ADYRK1ACYP19A1TNF
SCHEMBL24492835 0.92 CYP19A1 (0.46) MEN1KMT2ACYP19A1MAPTGRM5
SCHEMBL24493048 0.91 CYP19A1 (0.36) MEN1KMT2ARAB9ACYP19A1TNF
SCHEMBL15369865 0.91 CYP19A1 (0.46) MEN1KMT2ADYRK1ACYP19A1MAPT
SCHEMBL15369845 0.91 CYP19A1 (0.46) MEN1KMT2ADYRK1ACYP19A1MAPT
SCHEMBL24492784 0.91 KDM4E (0.43) MEN1KMT2ARAB9AMAPTMKNK1
SCHEMBL24492822 0.91 MKNK1 (0.42) MEN1KMT2ADYRK1ATNFMAPT
SCHEMBL15369926 0.90 CYP19A1 (0.43) MEN1KMT2ARAB9ACYP19A1TNF
SCHEMBL15369929 0.90 CYP19A1 (0.43) MEN1KMT2ARAB9ACYP19A1TNF
SCHEMBL15369940 0.89 CYP19A1 (0.42) MEN1KMT2ARAB9ACYP19A1TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT ETV6, LEF1, TEAD2 MEN1 2474/4885KMT2A 1870/4885RAB9A 3859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback